Bristol-Myers hepatitis C treatment cures up to 90 pct -study
April 10, 2014 at 07:00 AM EDT
April 10 (Reuters) - A combination of two anti-viral drugs developed by Bristol-Myers Squibb Co cured 90 percent of previously untreated hepatitis C patients and 82 percent of those who failed to respond to prior therapy, according to results from a late stage study presented on Thursday.